Latest News
-
Research identifies health impact of traffic accidents
Posted on:
Clinician and Kolling Institute researcher Professor Ashley Craig said their results follow a five year study involving more than 2,000 people injured in a motor vehicle accident. “One in three people injured in a traffic accident suffer depression and experience post-traumatic stress symptoms,” Professor Craig said. “By following patients over a long period of time,
Category:
-
Delivering presentations people remember
Posted on:
Kolling Institute cancer researchers were given an opportunity to spend the day with presenter Julie McCrossin. Julie spent more than 20 years as a radio broadcaster and is now a freelance journalist, facilitator, trainer and speaker. Julie invests a large share of her time supporting research initiatives, and in recent years has received treatment for
Category:
-
Kolling researchers part of elite group in fight against heart disease
Posted on:
Two Kolling Institute researchers have welcomed a significant funding boost through a large NSW Government program to help tackle Australia’s number one killer, heart disease. Professors Gemma Figtree and Martin Ugander have each been awarded a $750,000 grant to encourage researchers to find breakthroughs and help establish NSW as a centre for research excellence. The
Category:
-
Northern Sydney leading the way with arthritis research and clinical care
Posted on:
The latest exciting research into musculoskeletal disease has been unveiled during the inaugural Northern Lights showcase. Close to 200 people attended the jam packed event in the Kolling auditorium, including clinicians, researchers and many people living with arthritic pain. RNSH Head of Rheumatology Professor Lyn March addressed the event, detailing the devastating cost of the
Category:
-
New world leading technology to guide future bowel cancer treatment
Posted on:
Research capabilities within the Kolling Institute have been significantly broadened with new technology to assist the examination of bowel cancer. Representatives from Sydney University, the Kolling and Bowel Cancer Australia attended the official opening of the mass spectrometry core lab – the first of its type on a hospital campus and one of the best
Category:
-
Recognition for the Kolling Director
Posted on:
The Kolling’s Director of Research Professor Carolyn Sue has been awarded a Member of the Order of Australia (AM) in this year’s Queen’s Birthday Honours for her significant service to medicine, particularly mitochondrial disease. Carolyn is a highly accomplished neurologist and is internationally regarded for her work in both Parkinson’s and mitochondrial disease. Recently appointed
Category:
-
-
-
New medication may offer long-acting relief for those with knee osteoarthritis
Posted on:
A study has been launched to investigate the benefits of a new injectable medication for those with knee osteoarthritis. The condition can have a profound impact on a person’s life, leading to physical limitations, ongoing pain and joint instability. There are broader implications too which can make it difficult for those with the condition to
Category:
-
Global focus on musculoskeletal health
Posted on:
Kolling researchers are part of an international team calling for musculoskeletal health to become a global priority, addressing a current lack of funding for the world’s leading cause of pain. The project team found the management of musculoskeletal health is under-prioritised despite its impact on the community, and devised an action plan to address this
Category:
